These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9712459)

  • 1. Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation.
    Moreno M; Manzanares C; Castellano F; Medina E; Urruzuno P; Camarena C; Manzanares J; Jara P
    Ther Drug Monit; 1998 Aug; 20(4):376-9. PubMed ID: 9712459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
    Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.
    Levy G; Villamil FG; Nevens F; Metselaar HJ; Clavien PA; Klintmalm G; Jones R; Migliaccio M; Prestele H; Orsenigo R;
    Am J Transplant; 2014 Mar; 14(3):635-46. PubMed ID: 24456049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
    Reggiani P; Orsenigo R; Gatti S; Albani AP; Ferla G; Doglia M; Fassati LR; Galmarini D
    Transplant Proc; 1994 Dec; 26(6):3597-8. PubMed ID: 7527982
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
    Hedayat S; Kershner RP; Su G
    J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
    Kugelmas M; Osgood MJ; Trotter JF; Bak T; Wachs M; Forman L; Kam I; Everson GT
    Liver Transpl; 2003 Nov; 9(11):1159-65. PubMed ID: 14586876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
    Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
    J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
    [No Abstract]   [Full Text] [Related]  

  • 14. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
    Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up.
    Pou L; Brunet M; Bilbao I; Andreu H; Andres I; Lopez R; Margarit C; Rimola A; Corbella J
    Ther Drug Monit; 1998 Dec; 20(6):602-6. PubMed ID: 9853973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
    Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.